NCT03028714 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P
International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95.
Kliemann N, Wardle J, Johnson F, Croker H
Reliability and validity of a revised version of the General Nutrition Knowledge Questionnaire. Eur J Clin Nutr. 2016 Oct;70(10):1174-1180. doi: 10.1038/ejcn.2016.87. Epub 2016 Jun 1.
Leppälä J, Lagström H, Kaljonen A, Laitinen K
Construction and evaluation of a self-contained index for assessment of diet quality. Scand J Public Health. 2010 Dec;38(8):794-802. doi: 10.1177/1403494810382476. Epub 2010 Sep 16.

The Impact of an Educational Intervention on Nutrition Knowledge, Dietary Habits, BMI and Physical Activity, in University Students in the United Kingdom (UK).

Details for clinical trial NCT03028714

Clinical trial NCT03028714 - References